AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Semperit AG Holding

Interim / Quarterly Report Aug 10, 2023

760_ir_2023-08-10_63d96044-961a-464b-bd57-e18300ae26c9.pdf

Interim / Quarterly Report

Open in Viewer

Opens in native device viewer

Key performance figures

in EUR million 1-6 2023 Change 1-6 2022 Q2 2023 Change Q2 2022 2022
Revenue 374.2 –5.2% 394.8 189.0 –11.4% 213.3 779.8
EBITDA 43.7 –18.9% 53.9 22.9 –31.9% 33.7 100.5
EBITDA margin 11.7% –2.0 PP 13.7% 12.1% –3.7 PP 15.8% 12.9%
EBIT 28.4 –26.8% 38.8 15.2 –41.7% 26.2 62.1
EBIT margin 7.6% –2.2 PP 9.8% 8.1% –4.2 PP 12.3% 8.0%
Earnings after taxes 3.9 –88.6% 34.7 3.5 –81.6% 19.2 –5.6
Earnings per share (EPS)1
, in EUR
0.20 –88.6% 1.68 0.18 –81.6% 0.93 –0.27
Gross cash flow 17.6 –62.6% 47.0 15.2 –12.5% 17.4 30.5
Return on equity2 1.7% –10.7 PP 12.4% 1.5% –18.2 PP 19.7% 45.7%

Balance sheet key figures

in EUR million 30.06.2023 Change 30.06.2022 31.03.2023 Change 31.03.2022 31.12.2022
Total assets 801.5 –17.4% 969.9 847.6 –15.0% 996.7 842.9
Equity 486.0 –12.7% 556.4 518.0 –7.6% 560.4 518.2
Equity ratio 60.6% +3.3 PP 57.4% 61.1% +4.9 PP 56.2% 61.5%
Additions to intangible assets
and property, plant and
equipment
12.6 –38.1% 20.3 5.4 –46.3% 10.0 50.1
Employees (at reporting date) 6,282 –9.4% 6,936 6,510 –7.1% 7,007 6,528

Sector and segment key figures

in EUR million 1-6 2023 Change 1-6 2022 Q2 2023 Change Q2 2022 2022
Industrial Sector = Semperflex + Semperseal + Sempertrans + Semperform
Revenue 355.7 –4.5% 372.3 179.3 –10.9% 201.3 734.0
EBITDA 64.2 –5.6% 68.0 33.6 –19.2% 41.5 125.2
EBIT 50.3 –7.7% 54.5 26.6 –23.6% 34.9 95.9
Semperflex
Revenue 138.2 –20.5% 173.7 65.5 –30.2% 93.9 328.8
EBITDA 32.6 –30.4% 46.8 15.9 –41.8% 27.3 82.2
EBIT 26.4 –35.5% 40.9 12.7 –47.5% 24.3 70.2
Semperseal
Revenue 64.2 –14.5% 75.1 32.2 –16.2% 38.4 142.1
EBITDA 4.1 –33.9% 6.3 2.6 –34.4% 3.9 8.3
EBIT 1.2 –58.5% 2.8 1.2 –49.3% 2.3 –0.6
Sempertrans
Revenue 93.6 34.1% 69.8 50.6 21.9% 41.5 151.9
EBITDA 16.7 n.a. 6.6 9.4 75.5% 5.3 19.7
EBIT 14.3 n.a. 4.7 8.1 85.0% 4.4 15.5
Semperform
Revenue 59.7 11.2% 53.7 30.9 12.5% 27.5 111.1
EBITDA 10.7 30.1% 8.3 5.8 14.6% 5.0 15.1
EBIT 8.5 39.2% 6.1 4.6 17.3% 4.0 10.8
Medical Sector = Sempermed
Revenue 81.6 –58.8% 198.3 42.1 –54.4% 92.3 324.2
EBITDA –20.3 n.a. 15.6 –8.7 n.a. 2.3 –15.4
EBIT –24.9 n.a. 2.9 –11.3 n.a. –4.7 –49.5

Note: Rounding differences in the totalling of rounded amounts and percentages may arise from the use of automatic data processing.

1 Earnings per share are only attributable to the core shareholders of Semperit AG Holding (excl. remuneration from hybrid capital). 2 Based on a full-year projection.

Foreword of the Executive Board

Dear Shareholders, dear Sir or Madam,

The Semperit Group took important steps in its transformation into an industrial rubber specialist in the first half of 2023. For example, the sale of the medical business progressed very well. We have now received all regulatory approvals and expect the closing to take place at the end of August 2023. Furthermore, the acquisition of the Rico Group was signed and was already completed at the end of July 2023. This will give Semperit a leading technological position in liquid silicone and highend tooling and strengthen its industrial core business. Together with Rico, we aim to exploit the great growth potential for silicone products in Western Europe and the USA.

Economic headwind

As expected, the Semperit Group's business performance in the first half of 2023 was characterised by the cooling economic climate. This led to a continuous reduction in inventories among customers and to restrained order behaviour. In anticipation of this development, we have already initiated countermeasures, which include strict cost management, streamlining of processes and the corresponding increase in operating efficiency in order to be able to respond flexibly to further market fluctuations.

In the first half of 2023, the Semperit Group generated revenue of EUR 374.2 million and EBITDA of EUR 43.7 million with its continued operations. As expected, this is below the comparable figures for the previous year (–5.2% in revenue and –18.9% in EBITDA) but represents a thoroughly solid performance in a challenging environment. In the Industrial Sector, for example, the EBITDA margin was kept virtually stable despite a 4.5% drop in revenue. It should also be noted that the result for the first half of 2023 includes negative non-recurring effects of around EUR 4.1 million from the acquisition of Rico and changes in the Executive Board. As expected, the result from discontinued operations developed negatively due to the sharp decline in sales volumes and prices for examination and surgical gloves. Overall, the Semperit Group's earnings after tax for the first half of 2023 were positive at EUR 3.9 million, compared to EUR 34.7 million in the same period of the previous year, primarily due to the end of the pandemic-related special cycle in the glove sector.

Efficient and powerful positioning

As part of our strategy of focusing on our industrial core business with even greater customer proximity, we have streamlined the organisation and structured our existing segments in two divisions. The Industrial Applications division focuses on industrial applications with highly efficient manufacturing and cost leadership in connection with large scale production, while the Engineered Applications division focuses on customised technical solutions.

Gerfried Eder is responsible for the Industrial Applications division on the Executive Board. He joined our Executive Board team on July 1 as Chief Industrial Officer (CIO) and has previously held various management positions at Semperit since 2000. The Engineered Applications division is headed by CEO Karl Haider, while CFO Helmut Sorger's responsibilities have remained essentially unchanged by the new organisational structure.

The new structure came into effect on July 1 2023 and thus after the reporting period. You will therefore still find the original segment reporting in this half-year report. However, we have already prepared a reconciliation to the new segment reporting, which will be applicable from the financial report for the first nine months of 2023 (page 40ff).

With its two divisions, which cover different customer groups and their specific requirements, the Semperit Group is efficiently and powerfully positioned for the future. In conjunction with our robust balance sheet structure and the cost reduction measures that have been initiated and will be implemented in the future, we believe that the group is well prepared for the current challenging environment and for further growth.

The Executive Board

Karl Haider CEO

Helmut Sorger CFO

Gerfried Eder CIO

Group Management Report

Economic environment

The International Monetary Fund (IMF) expects global economic growth to slow from 3.5% in the previous year to 3.0% in 2023. This means that the global economy will be somewhat stronger than forecast in April 2023 (2.8%). However, there are still numerous challenges to be tackled, the IMF's economists emphasise. By comparison, the long-term average for the years 2000 to 2019 is 3.8%. The year-on-year slowdown is mainly concentrated in the highly developed economies: the eurozone, for example, is expected to grow by just 0.9% this year (April forecast: 0.8%) after 3.5% in 2022, while growth in the U.S. economy is expected to weaken to 1.8% (April forecast: 1.6%) after 2.1% in the previous year. By contrast, the emerging and developing economies are expected to maintain the 4.0% growth this year, which they achieved in 2022 (April forecast: 3.9%).

Even though some risks have diminished, there are more and more signs that global economic activity is losing momentum, according to the IMF. The main influencing factors are the high key interest rates impacting the economy, a possible slowdown in the recovery in China, partly due to unresolved real estate problems, with negative effects on the global economy, and still high core inflation.

Development in the raw material markets

Various raw materials, such as butadiene, carbon black and natural rubber, are important basic components for manufacturing polymer products. Following supply shortages for a number of raw materials and sharp price increases in the first half of 2022 due to the geopolitical environment, the situation largely eased in the reporting period. The exceptions were carbon black prices, which were mainly impacted by a supply shortage and energy and CO2 surcharges. The following charts show an overview of the most important raw materials:

Indexed to January 1, 2020; source: Reuters, Refinitiv Eikon;

Brent Crude, LCOc1 ICE Europe Brent Crude Electronic Energy Future (USD/bbl)

HFO, Heavy Fuel Oil 1% NWE (USD/t) Butadiene, PHAKE00 BD Korea, PHAKG00 BD Europe (USD/t)

Technically Specified Rubber, TSR20 SICOM (Usc/kg)

Crude oil is an important starting material for synthetic rubber feedstocks such as butadiene, but also for carbon black. In parallel with the decline in crude oil prices, average prices for the basic raw material butadiene, which is relevant for all segments, were around 20% lower in the first half of the year than in the prior-year period in both Asia and Europe. This was also reflected in the price development for butadiene derivatives.

In the past, prices for carbon black, a filler used in the entire Industrial Sector, have generally correlated strongly with the development of heavy fuel oil (HFO), which was 29% cheaper on average in the first half of the year than in the comparative period. However, there has been a decoupling, as the war in Ukraine and energy and CO2 surcharges have had a significant impact in the last 15 months. Overall, carbon black prices were therefore higher in the first half of the year than in the comparative period.

Natural rubber (important especially for Sempertrans) and natural latex (important for Sempermed) were traded on the Asian commodity exchanges at around 20% and 21% lower prices, respectively, than in the same period of the previous year.

Nitrile latex, which is the most important raw material for Sempermed, also experienced a significant decrease due to declining demand and lower butadiene prices.

The price for iron ore, which is used in wire rod, was 16% lower than in the previous year, but above the five-year average.

Revenue and earnings performance

Key figures Semperit Group

in EUR million 1-6 2023 Change 1-6 2022 2022
Revenue 374.2 –5.2% 394.8 779.8
EBITDA 43.7 –18.9% 53.9 100.5
EBITDA margin 11.7% –2.0 PP 13.7% 12.9%
EBIT 28.4 –26.8% 38.8 62.1
EBIT margin 7.6% –2.2 PP 9.8% 8.0%
Earnings after tax from continued operations 17.9 –34.1% 27.2 38.4
Earnings after tax from discontinued operations –14.0 n.a. 7.6 –44.0
Earnings after tax 3.9 –88.6% 34.7 –5.6
Additions to intangible assets and property,
plant and equipment
12.6 –38.1% 20.3 50.1
Employees (at reporting date) 6,282 –9.4% 6,936 6,528

In the first half of the year, the Semperit Group recorded a solid performance in a challenging market environment characterised by high inflation and an incipient economic cooldown. Revenue of EUR 374.2 million was generated, which was –5.2% below the comparable figure for the previous year. Positive price effects could not fully compensate for lower sales volumes, as customer-side inventory optimisation led to more cautious ordering behaviour, as expected. EBITDA from the continued operations amounted to EUR 43.7 million (1-6 2022: EUR 53.9 million), which included one-time expenses of EUR 4.1 million from the Rico-acquisition and from changes in the Executive Board. As expected, earnings from discontinued operations developed negatively. Earnings after tax were positive at EUR 3.9 million.

In the first half of 2023, the continued operations of the Semperit Group recorded revenue of EUR 374.2 million (–5.2%). In the Industrial Sector, the cyclical and market-related decline was –4.5% to EUR 355.7 million, and in the continued operations in the Medical Sector (production of surgical gloves in Wimpassing including packaging in Sopron) revenue decreased by –17.9% to EUR 18.5 million.

While the segment Sempertrans continued to benefit from a positive market environment and achieved significant volume and price growth, the development of the other industrial segments reflected the challenging market environment, resulting in partially significantly lower volumes at stable prices.

Inventories of own products of continued operations increased by EUR 3.8 million in the first six months of 2023 (1-6 2022: increase by EUR 17.0 million).

Cost of materials (including energy and purchased services) decreased by EUR 31.6 million, or 14.9%, to EUR 180.8 million in the first half of 2023. This was predominantly due to lower production volumes.

Personnel expenses increased to EUR 107.7 million (+6.1%) in the first half of 2023, mainly due to inflation-related wage and salary increases, which were partly offset by capacity-related adjustments to the headcount, as well as through one-off severance payments in connection with the changes in the Executive Board.

At EUR 50.1 million, other operating expenses were +6.6% higher than in the same period of the previous year (1-6 2022: EUR 47.0 million). This is attributable in particular to the acquisition of the Rico Group (EUR 2.7 million) and to a warranty case. In addition, there were higher maintenance costs as well as increased travel costs as business travel picked up again after the corona pandemic.

EBITDA in continued operations amounted to EUR 43.7 million (–18.9%), while the EBITDA margin in continued operations was 11.7% (1-6 2022: 13.7%).

Depreciation and amortisation in continued operations remained de facto unchanged at EUR 15.3 million (1-6 2022: EUR 15.1 million). Therefore, EBIT in continued operations amounted to EUR 28.4 million (1-6 2022: EUR 38.8 million).

The financial result of continued operations improved to EUR –2.4 million (1-6 2022: EUR –4.2 million). This is attributable to the change in result attributable to redeemable noncontrolling interests.

Tax expense in continued operations amounted to EUR 8.1 million (1-6 2022: EUR 7.4 million). In the first half of 2023, the effective tax rate of continued operations was 29.4% compared to 19.7% in the same period of the previous year. Due to the recognition of deferred tax assets in the first half of 2022, the effective tax rate was comparatively low at that time. Here, the effective tax rate refers to income taxes in relation to earnings before tax less profit or loss attributable to redeemable noncontrolling interests.

Earnings after tax from continued operations were EUR 17.9 million (1-6 2022: EUR 27.2 million). Earnings after tax from discontinued operations amounted to EUR –14.0 million (1-6 2022: EUR 7.6 million). Further details on discontinued operations will follow in the next chapter.

Overall, earnings after tax (from continued and discontinued operations) were positive at EUR 3.9 million (1-6 2022: EUR 34.7 million). Earnings per share attributable to the shareholders of Semperit AG Holding amounted therefore to EUR 0.20 for the first half of 2023 (1-6 2022: EUR 1.68).

Discontinued operations

Following the pandemic-related special cycle with comparatively high demand and price development, revenue from discontinued operations decreased significantly to EUR 81.6 million in the first half of 2023 (1-6 2022: EUR 198.3 million). Sales volumes were 42.1% and average selling prices 16.7% lower than in the same period of the previous year.

Due to lower production volumes, cost of materials decreased by 39% to EUR 72.0 million (1-6 2022: EUR 118.9 million). This includes material expenses of EUR 18.5 million for surgical gloves, as pre-packaged surgical gloves are currently, and will continue to be, sold by Semperit Technische Produkte GmbH to Semperit Investments Asia Pte Ltd. (currently still part of the Group; after the closing of the sale of the medical business to HARPS GLOBAL PTE. LTD. it will be external to the Group) in accordance with the contract manufacturing agreement with HARPS, which then sells the products of the Sempermed segment to customers. Personnel expenses amounted to EUR 14.2 million due to savings by EUR 5.3 million or 27%, which resulted from the reduction of temporary workers and of vacation accruals. Significantly lower freight costs led to a 54% decrease in other operating expenses to EUR 10.4 million.

As expected, EBITDA in the discontinued operations of the Medical Sector thus turned negative and amounted to EUR –15.5 million after the comparative period in 2022, which was still positively impacted by volumes and prices (1-6 2022: EUR 21.3 million).

Due to the signing of the sale agreement with HARPS GLOBAL PTE. LTD., it was possible to determine a fair value for the segment assets of Sempermed as of 30 June 2023 based on the selling price and taking into account the intended price adjustment mechanism. Directly attributable disposal costs still expected to be incurred were to be deducted. The resulting reversal of impairment losses on the assets of the discontinued operations totalled EUR 1.6 million as of 30 June 2023.

EBIT in the discontinued operations thus amounted to EUR –14.0 million (1-6 2022: EUR 9.6 million).

Semperit Group "as-if", no separation from the discontinued operation

The following table shows the results based on segment reporting. The segmentation by business areas is based on internal management and reporting and also includes the Sempermed segment as a whole.

This "as-if" presentation shows the figures as if the separation into continued and discontinued operations had not (yet) taken place. The earnings figures take into account the continued and discontinued operations as well as all consolidation entries necessary at Group level.

Key figures Semperit Group

in EUR million 1-6 2023 Change 1-6 2022
Revenue 437.4 –23.4% 570.6
EBITDA 27.9 –62.9% 75.2
EBITDA margin 6.4% –6.8 PP 13.2%
EBIT 8.8 –81.8% 48.4
EBIT margin 2.0% –6.5 PP 8.5%

Second quarter of 2023

Key figures Semperit Group

in EUR million Q2 2023 Change Q2 2022
Revenue 189.0 –11.4% 213.3
EBITDA 22.9 –31.9% 33.7
EBITDA margin 12.1% –3.7 PP 15.8%
EBIT 15.2 –41.7% 26.2
EBIT margin 8.1% –4.2 PP 12.3%
Earnings after tax 3.5 –81.6% 19.2
Additions to intangible assets and property, plant and
equipment 7.2 –30.1% 10.3
Employees (at reporting date) 6,282 –9.4% 6,936

The Semperit Group generated revenue of EUR 189.0 million in the second quarter of 2023, down –11.4% on the previous year (Q2 2022: EUR 213.3 million). The Industrial Sector recorded a decline in revenue of –10.9% due to market and demand factors. With regard to the development of sales volumes and selling prices, the reasons for the development in the first half of 2023 essentially also apply to the second quarter of 2023.

Cost of materials decreased by 23.3% to EUR 84.7 million in the second quarter of 2023 compared to the same period of the previous year. The change was largely due to lower production volumes in the Semperflex, Semperseal and Semperform segments.

Personnel expenses increased by 6.4% to EUR 55.0 million compared to the same period of the previous year. Inflation-related wage and salary increases were not entirely offset by savings in headcount (mainly temporary workers). In addition, there were one-off severance payments in connection with the changes on the Executive Board.

Other operating expenses increased slightly to EUR 25.7 million (Q2 2022: EUR 24.7 million). Higher warranty, maintenance and travel expenses were partially offset by lower freight costs.

EBITDA thus amounted to EUR 22.9 million in the second quarter of 2023 (Q2 2022: EUR 33.7 million).

Dividend

At the 134th Annual General Meeting on 25 April 2023, the shareholders approved Semperit AG Holding's dividend proposal and resolved to distribute a basic dividend of EUR 1.50 per share plus a conditional additional dividend of EUR 3.00 per share for the 2022 financial year. The payment of the basic dividend has already been completed. The entitlement to the additional dividend and its payment are subject to the following conditions precedent: sale of the medical business (Sempermed; initially production of examination gloves including sales organisation) by 16 September 2023, transfer of the medical business to the buyer by 31 October 2023 and full receipt of the purchase price. Within 7 calendar days after the fulfilment of the above conditions, Semperit AG Holding will obtain a confirmation regarding the fulfilment of the conditions and, immediately after receipt of the confirmation, will announce in a supplementary dividend announcement whether the above conditions have been met. This announcement will also contain the technical modalities of the supplementary dividend payment, whereby the supplementary dividend is to be paid within 21 calendar days after the fulfilment of the above conditions precedent. Currently, the transaction is expected to close at the end of August. If the conditions precedent do not come into effect, the Company will announce this.

Assets and financial position

Balance sheet

The development of the balance sheet structure as of 30 June 2023 can be summarised as follows:

in EUR million 30.06.2023 Share 31.12.2022 Share Change
Non-current assets 325.2 41% 316.6 38% +2.7%
Current assets 313.6 39% 338.4 40% –7.3%
Assets held for sale 162.7 20% 187.9 22% –13.4%
ASSETS 801.5 100% 842.9 100% –4.9%
Equity1 486.7 61% 519.1 62% –6.3%
Non-current provisions and liabilities 127.0 16% 115.9 14% +9.6%
Current provisions and liabilities 148.0 18% 161.0 19% –8.1%
Provisions and liabilities held for sale 39.9 5% 46.9 6% –15.0%
EQUITY AND LIABILITIES 801.5 100% 842.9 100% –4.9%

1 incl. non-controlling interests

Non-current assets changed only slightly and were influenced, among other things, by additions to non-current assets amounting to EUR 12.6 million, an increase in other assets of EUR 6.6 million, a positive FX effect of EUR 2.3 million, and regular depreciation and amortisation of EUR 15.3 million.

Current assets decreased by 7.3% compared to 31 December 2022. Decreases in cash and cash equivalents of EUR 17.8 million and in inventories of EUR 13.5 million were offset by higher trade receivables (EUR +10.5 million).

Equity primarily reflects the dividend payment made.

The increase in non-current liabilities and provisions resulted primarily from a EUR 9.8 million increase in liabilities to banks for the expansion investment in the Czech Republic (DH5).

Current liabilities and provisions decreased by EUR 13 million or 8.1%. The main positive factors here were decreases in trade payables of EUR 5.4 million and in liabilities from redeemable noncontrolling interests of EUR 6.7 million.

As of 30 June 2023, the Semperit Group recorded a net cash surplus of EUR 25.9 million for continued operations, as cash and cash equivalents and cash equivalents (EUR 88.9 million) exceeded financial liabilities (EUR 63.0 million). The calculated ratio between net cash surplus (i.e., theoretical negative net indebtedness) and EBITDA as of 30 June 2023 was thus –0.6x (December 31, 2022: –0.6x).

New bank financing – totalling up to EUR 360 million – was concluded with effect from 31 March 2023. A financing agreement totalling EUR 250 million consists of a loan of up to EUR 150 million and a credit facility line of EUR 100 million. In this financing agreement, Semperit AG Holding has committed itself to compliance with three ESG key figures, which are also part of the sustainability strategy "30 by 2030". This financing is provided by a group of six Austrian and international banks and replaces an earlier framework credit line amounting to EUR 75 million. In July 2023, and thus after the reporting period, the loan amounting to EUR 150 million was drawn for the completion of the acquisition of the Rico Group. The second agreement amounting to EUR 110 million was concluded particularly for the expansion investment at the Odry site. Of this amount, EUR 10 million was drawn during the reporting period.

Cash flow

The cash flow statement is prepared jointly for the continued and discontinued operations; no distinction is made between the cash flows of the individual business units. The cash flows from operating, investing and financing activities of the discontinued operation are disclosed in the notes.

The development of the liquidity situation in the first half year of 2023 can be summarised as follows:

in EUR million 1-6 2023 Change 1-6 2022
Cash flow from operating activities 22.7 –1.2% 23.0
Cash flow from investing activities –20.4 –25.9% –27.6
Free cash flow 2.3 n.a. –4.6
Cash flow from financing activities –30.8 –29.9% –43.9
Net increase/decrease in cash and cash equivalents –30.5 –27.8% –42.2
Cash and cash equivalents at the end of the period 127.4 –34.1% 193.3

In the first half of 2023, cash flow from operating activities was almost stable despite the lower earnings. This was mainly due to a reduction in inventories in the reporting period.

At EUR 21.9 million, cash expenditures in intangible assets and property, plant and equipment in the first six months of 2023 were below the prior-year level (1-6 2022: EUR 28.4 million). The largest investments were made in the Czech Republic with EUR 9.1 million (1-6 2022: EUR 2.6 million), Austria with EUR 5.6 million (1-6 2022: EUR 7.5 million), Germany with EUR 2.2 million (1-6 2022: EUR 1.8 million) and Poland with EUR 1.9 million (1-6 2022: EUR 1.6 million). The comparative figure for the previous year included investments in Malaysia amounting to EUR 11.2 million.

Free cash flow (the balance of cash flow from operating activities and cash flow from investing activities) was EUR 2.3 million after EUR –4.6 million in the comparative period.

Cash flow from financing activities in the first half of 2023 included in particular dividends to the shareholders of Semperit AG Holding amounting to EUR 30.9 million (1-6 2022: EUR 30.9 million), dividends to redeemable non-controlling interests in subsidiaries of EUR 6.4 million (1-6 2022: EUR 5.7 million), the repayment of lease liabilities with a volume of EUR 2.0 million (1-6 2022: EUR 1.6 million) and the cash receipt of financial liabilities of EUR 10 million (1-6 2022: EUR –4.9 million). In the comparative period, this item included the repayment of a current financial liability in Malaysia amounting to EUR 4.8 million.

Related-party transactions with companies and individuals

With regard to the related-party transactions with companies and individuals please refer to the Interim Consolidated Financial Statements.

Performance of sectors and segments

Industrial Sector

Key figures Industrial Sector

in EUR million 1-6 2023 Change 1-6 2022 Q2 2023 Change Q2 2022 2022
Revenue 355.7 –4.5% 372.3 179.3 –10.9% 201.3 734.0
EBITDA 64.2 –5.6% 68.0 33.6 –19.2% 41.5 125.2
EBITDA margin 18.0% –0.2 PP 18.3% 18.7% –1.9 PP 20.6% 17.1%
EBIT 50.3 –7.7% 54.5 26.6 –23.6% 34.9 95.9
EBIT margin 14.1% –0.5 PP 14.6% 14.9% –2.5 PP 17.3% 13.1%
Additions to intangible assets
and property, plant and
equipment 11.8 +23.4% 9.6 6.8 +29.1% 5.3 32.2
Employees (at reporting date) 3,699 –4.9% 3,892 3,699 –4.9% 3,892 3,764
  • Partly still high inventories and a continuous reduction of inventories of customers as well as the slowdown of the economic development and the associated lower demand, especially for products of Semperflex, Semperform and Semperseal, led to a lower order intake in the first half of 2023, as expected. Overall, the order book of the Industrial segments was around 45% below the aboveaverage level of the corresponding prior-year period.
  • The gradual increases of prices from the 2022 financial year had a lagging positive effect in average. The decline in volumes resulted in a 4.5% decline in revenue.
  • The cost level in the first half of 2023 was slightly lower than in the same period of the previous year – following a sharp increase particularly in the second and third quarters of 2022 and an incipient recovery since the fourth quarter of 2022. The slight easing in material costs was offset by higher personnel expenses and other expenses due to inflation. The latter resulted mainly from the acquisition of the Rico Group.

Semperflex segment

Key figures Semperflex

in EUR million 1-6 2023 Change 1-6 2022 Q2 2023 Change Q2 2022 2022
Revenue 138.2 –20.5% 173.7 65.5 –30.2% 93.9 328.8
EBITDA 32.6 –30.4% 46.8 15.9 –41.8% 27.3 82.2
EBITDA margin 23.6% –3.4 PP 27.0% 24.2% –4.8 PP 29.0% 25.0%
EBIT 26.4 –35.5% 40.9 12.7 –47.5% 24.3 70.2
EBIT margin 19.1% –4.5 PP 23.5% 19.4% –6.4 PP 25.8% 21.4%
Additions to intangible assets
and property, plant and
equipment
5.7 +89.1% 3.0 4.1 n.a. 2.0 16.6
Employees (at reporting date) 1,627 –12.0% 1,849 1,627 –12.0% 1,849 1,782

• Demand and order intake were impacted by partially still high inventory levels and destocking by customers, as well as by the onset of the economic slowdown.

  • Revenue in the first half of 2023 was lower than in the previous year.
  • On the cost side, on the one hand the situation eased compared to the 2022 financial year, mainly due to lower volumes sold. On the other, in contrast, higher expenses for wages and salaries due to inflation were recorded. In addition, capacity adjustments in human resources have already been initiated.

Semperseal segment

Key figures Semperseal

in EUR million 1-6 2023 Change 1-6 2022 Q2 2023 Change Q2 2022 2022
Revenue 64.2 –14.5% 75.1 32.2 –16.2% 38.4 142.1
EBITDA 4.1 –33.9% 6.3 2.6 –34.4% 3.9 8.3
EBITDA margin 6.5% –1.9 PP 8.4% 7.9% –2.2 PP 10.1% 5.8%
EBIT 1.2 –58.5% 2.8 1.2 –49.3% 2.3 –0.6
EBIT margin 1.8% –1.9 PP 3.7% 3.6% –2.3 PP 5.9% –0.4%
Additions to intangible assets
and property, plant and
equipment
3.0 –25.0% 4.0 1.1 –48.6% 2.1 7.2
Employees (at reporting date) 480 –15.2% 566 480 –15.2% 566 560
  • The construction industry, as one of the most important customers, is burdened by the significantly higher interest rate environment, cost increases and weakness in the new construction business. This was reflected in a lower order intake and a correspondingly low order book level.
  • Volumes sold were lower than in the first half of 2022.
  • Cost reduction measures have already been initiated.

Sempertrans segment

Key figures Sempertrans

in EUR million 1-6 2023 Change 1-6 2022 Q2 2023 Change Q2 2022 2022
Revenue 93.6 +34.1% 69.8 50.6 +21.9% 41.5 151.9
EBITDA 16.7 n.a. 6.6 9.4 +75.5% 5.3 19.7
EBITDA margin 17.8% +8.4 PP 9.5% 18.5% +5.6 PP 12.9% 12.9%
EBIT 14.3 n.a 4.7 8.1 +85.0% 4.4 15.5
EBIT margin 15.3% +8.5 PP 6.7% 16.0% +5.4 PP 10.5% 10.2%
Additions to intangible assets
and property, plant and
equipment
0.9 +24.0% 0.7 0.5 +21.7% 0.4 3.6
Employees (at reporting date) 897 +2.0% 879 897 +2.0% 879 889
  • Demand in Sempertrans's late-cycle business in the first six months of 2023 continued to be driven by the positive effects of the favourable price development for mining products and the resulting high demand for conveyor belts.
  • Order intake developed very well, particularly in the second quarter, exceeding the very good level of the first half of 2022. As a result, the high order book level was maintained at a stable level.
  • The significant increase in revenue thus resulted from positive volume and price deviations.
  • Higher capacity utilisation and accordingly a higher operating leverage led to an increase in margins.

Semperform segment

Key figures Semperform

in EUR million 1-6 2023 Change 1-6 2022 Q2 2023 Change Q2 2022 2022
Revenue 59.7 +11.2% 53.7 30.9 +12.5% 27.5 111.1
EBITDA 10.7 +30.1% 8.3 5.8 +14.6% 5.0 15.1
EBITDA margin 18.0% +2.6 PP 15.4% 18.7% +0.3 PP 18.3% 13.6%
EBIT 8.5 +39.2% 6.1 4.6 +17.3% 4.0 10.8
EBIT margin 14.2% +2.9 PP 11.4% 15.0% +0.6 PP 14.4% 9.7%
Additions to intangible assets
and property, plant and
equipment
2.2 +19.4% 1.9 1.2 +48.2% 0.8 4.8
Employees (at reporting date) 696 +16.2% 599 696 +16.2% 599 591

• Overall, demand for the individual products in the segment showed a mixed picture. Order intake was similar to the level of last year, while the order book level came in below.

  • In the first half of 2023, overall sales volumes were slightly lower than a year earlier, with the Engineered Solutions business unit particularly impacted by lower demand from the railroad superstructure business.
  • Higher prices as a result of the step-by-step increases implemented in 2022 and an improved product mix with a stronger focus on Special Applications outweighed the decline in sales and led to an increase in revenue in the first half of 2023.
  • Likewise, higher average price levels more than offset the significantly higher costs since the first quarter of 2022 – although these costs were slightly lower in the first half of 2023. This positive effect is reflected in EBITDA, EBIT and the corresponding margins.

Medical Sector: Sempermed segment

Key figures Sempermed

in EUR million 1-6 2023 Change 1-6 2022 Q2 2023 Change Q2 2022 2022
Revenue 81.6 –58.8% 198.3 42.1 –54.4% 92.3 324.2
EBITDA –20.3 n.a. 15.6 –8.7 n.a. 2.3 –15.4
EBITDA margin –24.9% –32.8 PP 7.9% –20.7% –23.2 PP 2.5% –4.7%
EBIT –24.9 n.a. 2.9 –11.3 n.a. –4.7 –49.5
EBIT margin –30.4% –31.9 PP 1.5% –26.9% –21.8 PP –5.1% –15.3%
Additions to intangible assets
and property, plant and
equipment 1.4 –85.0% 9.2 0.7 –85.8% 4.7 15.0
Employees (at reporting date) 2,506 –15.6% 2,969 2,506 –15.6% 2,969 2,597

The Medical segment is considered as a whole, without division into discontinued operations and continued operations.

  • As expected, demand in the first half of 2023 continued to be characterised by customers significantly reducing inventory, excess production capacity and further intensified competition for examination and surgical gloves.
  • Sales volumes of surgical gloves were lower than in the prior-year period; sales volumes of examination gloves declined significantly.
  • In addition to the decline in revenue, EBITDA was impacted by higher costs as a result of low capacity utilisation and high fixed costs due to inflation.

Employees

The headcount as of 30 June 2023 for continued and discontinued operations totalled 6,282 employees (FTE, full-time equivalents), which is 9.4% lower than at 30 June 2022 (6,936). This was a result of capacity adjustments in the difficult economic environment. In the Industrial Sector, the Semperflex and Semperseal segments saw decreases of –12.0% and –15.2%, respectively, while Semperform and Sempertrans recorded increases of 16.2% and 2.0%, respectively. The Medical Sector recorded a decrease in headcount of –15.6% compared to 30 June 2022.

Executive and Supervisory Board matters

At the 134th Annual General Meeting on 25 April 2023, the shareholders elected Thomas Cord Prinzhorn and Marion Weissenberger-Eibl as new members of the Supervisory Board until the end of the Annual General Meeting which resolves on the ratification of actions for the 2025 financial year.

Claus Möhlenkamp and Klaus Erkes were re-elected as Supervisory Board members until the end of the Annual General Meeting which will decide on the discharge for the 2026 financial year.

At the constituent meeting of the Supervisory Board held after the Annual General Meeting, Thomas Cord Prinzhorn was elected Chairman and Stefan Fida Deputy Chairman of the Supervisory Board. Stefan Fida had previously chaired the supervisory body on an interim basis since December 2022.

On 20 June 2023, the Supervisory Board appointed Gerfried Eder as a member of the Executive Board (Chief Industrial Officer), effective as of 1 July 2023. He has worked for Semperit since 2000 and was most recently responsible for the Semperflex segment (hydraulic and industrial hoses) as Managing Director & Director Sales. Also on 20 June 2023, the Supervisory Board approved the early termination of Kristian Brok's Executive Board contract as of 30 June 2023. Kristian Brok left the company at his own request to pursue a new professional challenge. He had been a member of the Executive Board since January 2020.

In Semperit's new organisational structure, which focuses on two business areas, CEO Karl Haider is responsible for the Engineered Applications division and CIO Gerfried Eder for the Industrial Applications division. The responsibilities of CFO Helmut Sorger remain basically unchanged.

Outlook

After a solid performance in continued operations in the first half of 2023, the Executive Board of the Semperit Group expects the market environment to remain challenging in the second half of 2023. It will be characterised by an economic slowdown and, on the customer side, by inventory reductions and more short-term ordering behaviour. As a result, lower sales volumes and increased price pressure are to be expected overall.

In addition, uncertainties due to geopolitical conflicts are still present and may quickly lead to adverse effects on the market environment.

Strict cost management

In anticipation of this development, countermeasures have already been initiated, which include strict cost management, streamlining of processes and the corresponding increase in operating efficiency in order to be able to respond flexibly to further market fluctuations. Defined and already established measures for savings comprise a run-rate of around EUR 10 million. Against this backdrop, the outlook for the financial year 2023 is confirmed, according to which EBITDA from continued operations is expected to be at the lower end of the range between EUR 70 and 90 million.

Consistent pursuit of strategy

The cornerstones of the Semperit Group's further developed strategy, which was approved by the Supervisory Board on 20 June 2023, are the implementation of the sale of Sempermed, the acquisition of the Rico Group, strengthening hose production with the expansion of the production site in Odry, Czech Republic, which is currently under construction, and the continued focus on industrial applications and elastomer-based technical solutions in conjunction with even greater customer proximity.

The process of the sale of the medical business has progressed very well. All regulatory approvals have been granted. The closing, which includes the transfer of the production of examination gloves and porcelain cloth moulds for glove manufacturing in Malaysia as well as the global sales and distribution units to the buyer HARPS, is therefore expected for the end of August 2023 from today's perspective. If all conditions are met, the payment of the additional dividend of EUR 3.0 per share resolved by the Annual General Meeting can then be made in September 2023.

Until the closing of the transaction, the medical business will continue to burden the earnings development of the Semperit Group.

An important step was also taken in the implementation of the growth strategy, which includes both acquisitions and internal projects: the acquisition of the Rico Group was successfully completed on 31 July 2023. Semperit thus achieves technology leadership in liquid silicone and high-end tooling and strengthens its industrial core business. This goes hand in hand with servicing high-growth industries, such as health care and industrial household applications, and an increase in presence on the North American market.

Overall, the Semperit Group believes that its leading position as a manufacturer of specialised polymer and elastomer products for industrial customers, its robust balance sheet structure, and the cost-cutting and efficiency-enhancing measures, which have been initiated and will be implemented in the future, position it well for the challenging market environment, which is fraught with greater uncertainties.

Note

This outlook is based on the assessments of the Executive Board as of 9 August 2023 and does not take into account the impact of potential acquisitions, divestments, or other unforeseeable structural and economic changes during the remainder of 2023. These assessments are subject to both known and unknown risks and uncertainties, which may result in actual events and outcomes differing from the statements made here.

Vienna, 9 August 2023

The Executive Board

Karl Haider CEO

Helmut Sorger CFO

Gerfried Eder

CIO

Consolidated income statement

in EUR thousand Note 1-6 2023 1-6 20221 Q2 2023 Q2 20221
Revenue 2.2 374,230 394,844 189,033 213,333
Changes in inventories 3,826 16,953 –3,249 5,292
Own work capitalised 1,107 1,322 545 742
Operating revenue 379,163 413,119 186,329 219,366
Other operating income 3,199 1,831 1,939 1,067
Cost of material and purchased services 2.3 –180,829 –212,475 –84,649 –110,353
Personnel expenses 2.4 –107,698 –101,547 –54,979 –51,676
Other operating expenses 2.5 –50,103 –47,000 –25,720 –24,740
Earnings before interest, taxes, depreciation and
amortisation (EBITDA)
2.1 43,733 53,928 22,919 33,663
Depreciation and amortisation of intangible assets and property,
plant and equipment
–15,303 –15,116 –7,672 –7,504
Earnings before interest and taxes (EBIT) 2.1 28,430 38,812 15,247 26,160
Finance income 756 141 470 88
Finance expenses –1,225 –1,436 –641 –705
Profit / loss attributable to redeemable non-controlling interests –1,603 –3,089 –639 –1,756
Other financial result –325 163 362 192
Financial result –2,397 –4,221 –448 –2,180
Earnings before taxes 26,033 34,591 14,798 23,979
Income taxes –8,132 –7,438 –5,191 –4,156
Earnings after taxes from continued operations 17,901 27,153 9,607 19,823
Earnings after taxes from discontinued operations 2.6 –13,961 7,560 –6,076 –648
Earnings after taxes 3,941 34,714 3,531 19,175
thereof attributable to the shareholders of Semperit AG
Holding – from ordinary shares
4,148 34,632 3,637 19,139
thereof attributable to non-controlling interests –207 81 –106 37
Earnings per share in EUR (basic and diluted)2 0.20 1.68 0.18 0.93
of which earnings per share in EUR from continued
operations (basic and diluted)
0.87 1.32 0.47 0.96
of which earnings per share in EUR from discontinued
operations (basic and diluted)
–0.67 0.36 –0.29 –0.03

1 The comparative figures were adjusted (see section 2.6).

2 Earnings per share only concern the ordinary shareholders of Semperit AG Holding.

Consolidated statement of comprehensive income

in EUR thousand Note 1-6 2023 1-6 2022 Q2 2023 Q2 2022
Earnings after taxes 3,941 34,714 3,531 19,175
Other comprehensive income that will not be recognised
through profit and loss in future periods
0 –286 0 0
Remeasurements of defined benefit plans 0 0 0 0
Income tax thereon 0 –286 0 0
Other comprehensive income that will be recognised through
profit and loss in future periods
–5,537 12,796 –4,805 7,672
Currency translation differences –5,537 12,796 –4,805 7,672
Other comprehensive income - total –5,537 12,509 –4,805 7,672
Comprehensive income –1,597 47,223 –1,274 26,847
thereof on earnings attributable to the shareholders of
Semperit AG Holding – from ordinary shares
–1,333 47,110 –1,129 26,790
thereof on earnings attributable to non-controlling interests –264 113 –145 57

Consolidated cash flow statement

in EUR thousand Note 1-6 2023 1-6 20221
Earnings before taxes 26,033 34,591
Earnings before taxes from discontinued operations² 2.6 –13,839 9,463
Depreciation, amortisation, impairment and reversal of impairment of intangible assets and
property, plant and equipment 13,711 26,787
Gain / loss from disposal of assets
(including current and non-current financial assets) 223 138
Change in non-current provisions 2,152 657
Profit / loss attributable to redeemable non-controlling interests 1,603 3,089
Net interest income (including income from securities) 302 1,132
Income taxes paid –10,754 –32,340
Other non-cash income / expense –1,849 3,527
Gross cash flow 17,582 47,044
Change in inventories 20,333 –18,037
Change in trade receivables –9,430 –41,261
Change in other receivables and assets 1,457 10,535
Change in trade payables –1,300 28,500
Change in other liabilities and current provisions –5,904 –3,772
Cash flows from operating activities 22,737 23,009
Proceeds from sale of property, plant and equipment 184 335
Purchases of intangible assets and property, plant and equipment –21,923 –28,376
Interest received 933 310
Investment grants received 365 93
Proceeds from the repayment of financial assets 0 720
Acquisition of financial assets 0 –663
Cash flows from investing activities –20,442 –27,582
Cash receipts and repayment from current and non-current financial liabilities 6.2 8,989 –4,869
Repayment of lease liabilities –1,960 –1,577
Dividend to shareholders of Semperit AG Holding 5.1 –30,860 –30,860
Dividends to redeemable non-controlling interests in subsidiaries –6,396 –5,718
Repayment of liabilities from capital repayment to non-controlling interests in subsidiaries 0 –345
Interest paid –538 –504
Cash flows from financing activities –30,765 –43,873
Currency translation differences –2,013 6,202
Net change in cash and cash equivalents –30,482 –42,244
Cash and cash equivalents at the beginning of the period related to continued operations 106,631 109,416
Plus cash and cash equivalents related to discontinued operations 51,274 126,123
Cash and cash equivalents at the beginning of the period (consolidated balance sheet
value) 157,906 235,539
Cash and cash equivalents at the end of the period 127,423 193,295
Less cash and cash equivalents related to discontinued operations 38,567 87,866
Cash and cash equivalents at the end of the period related to continued operations
(consolidated balance sheet value)
88,856 105,429

1 The comparative figures were adjusted (see section 2.6).

2 Earnings before taxes from discontinued operations comprise earnings before taxes of EUR –13,579 thousand (previous year: EUR 9,463 thousand) and transaction

costs of EUR –260 thousand (previous year: EUR 0 thousand), see section 2.6.

Consolidated balance sheet

in EUR thousand Note 30.06.2023 31.12.2022
Intangible assets 5,601 6,283
Property, plant and equipment 3.1 296,450 293,531
Other financial assets 6.1 5,691 5,628
Other assets 12,436 5,842
Deferred tax assets 5,022 5,344
Non-current assets 325,200 316,628
Inventories 114,696 128,214
Trade receivables 6.1 99,383 88,861
Other financial assets 6.1 2,100 2,457
Other assets 8,371 11,241
Current tax receivables 194 1,010
Cash and cash equivalents 6.1 88,856 106,631
Current assets 313,599 338,414
Assets held for sale 4 162,725 187,875
ASSETS 801,525 842,917
Share capital 21,359 21,359
Capital reserves 21,503 21,503
Retained earnings 455,424 482,136
Currency translation reserve –12,305 –6,825
Equity attributable to the shareholders of Semperit AG Holding 485,981 518,174
Non-controlling interests 707 970
Equity 486,688 519,145
Provisions 32,227 32,134
Liabilities from redeemable non-controlling interests 6.2 13,242 12,162
Financial liabilities 6.2 47,772 37,956
Trade payables 6.2 92 52
Other financial liabilities 6.2 19,170 18,925
Other liabilities 2,207 1,995
Deferred tax assets 12,300 12,629
Non-current provisions and liabilities 127,009 115,854
Provisions 23,218 23,442
Liabilities from redeemable non-controlling interests 0 6,745
Financial liabilities 6.2 15,215 14,503
Trade payables 6.2 58,538 63,890
Other financial liabilities 6.2 11,461 9,553
Other liabilities 33,978 35,289
Current tax liabilities 5,556 7,586
Current provisions and liabilities 147,966 161,009
Provisions and liabilities held for sale 4 39,861 46,909
EQUITY AND LIABILITIES 801,525 842,917

Consolidated statement of the changes in equity

Note Share
capital
Capital
reserves
Retained
earnings
Currency
translation
reserve
Total control
ling
interests
Total
equity
21,359 21,503 512,216 –14,956 540,122 1,028 541,151
0 0 34,632 0 34,632 81 34,714
0 0 –286 12,764 12,478 31 12,509
0 0 34,346 12,764 47,110 113 47,223
5.1 0 0 –30,860 0 –30,860 0 –30,860
21,359 21,503 515,702 –2,192 556,373 1,141 557,513
21,359 21,503 482,136 –6,825 518,174 970 519,145
0 0 4,148 0 4,148 –207 3,941
0 0 0 –5,481 –5,481 –57 –5,537
0 0 4,148 –5,481 –1,333 –264 –1,597
5.1 0 0 –30,860 0 –30,860 0 –30,860
21,359 21,503 455,424 –12,305 485,981 707 486,688
Non

Notes to the half-year consolidated financial statements (condensed)

1. General

1.1. Basic compilation principles

The half-year consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (IFRSs) as well as IAS 34 for interim financial statements.

For more information on accounting and valuation methods of the Semperit Group, please see the consolidated financial statements as at 31 December 2022, which in this regard form the basis for these half-year consolidated financial statements.

The reporting currency is the euro, with figures rounded to the nearest thousand, unless expressly stated otherwise. Rounding differences in the totalling of rounded amounts and percentages may arise from the automatic processing of data.

The management of the Semperit Group reached an agreement on 16 December 2022 with the Southeast Asian glove producer, HARPS GLOBAL PTE. LTD., which is headquartered in Singapore and maintains production facilities in Malaysia, regarding the sale of the Sempermed segment. As far as the production of examination gloves and the production of porcelain dip mouldings (including the worldwide marketing and sales organisations of the Sempermed segment) are concerned, the conditions for a presentation in discontinued operations were given. For the time being, however, the production of surgical gloves will remain with the Semperit Group and thus will be shown in continued operations.

The present half-year consolidated financial statements of the Semperit Group as at 30 June 2023 have not been fully audited or reviewed by the Group's auditor.

1.2. New and amended accounting standards

The following new/amended standards and interpretations were applied for the first time (in some cases early) in the first half year 2023:

Endorsement Mandatory application
for the Semperit
Group
Effects on the
Semperit Group
New standards and interpretations
IFRS 17 Insurance Contracts 19 November 2021 1 January 2023 no
Amended standards
IAS 1 Amendments to the presentation of the financial statement:
disclosure of accounting standards
2 March 2022 1 January 2023 no
IAS 8 Amendments to accounting policies, amendments to
accounting estimates and errors: definition of accounting
estimates
2 March 2022 1 January 2023 no
IAS 12 Amendments to deferred taxes related to assets and liabilities
arising from a single transaction
11 August 2022 1 January 2023 no
Miscellan
eous
Amendments to the initial application of IFRS 17 and IFRS 9 –
comparative information
8 September 2022 1 January 2023 no

2. Performance

2.1. Segment reporting

Neither the presentation nor the measurement rules pursuant to IFRS 5 applicable to discontinued operations were applied in connection with internal segment reporting.

1-6 2023 in EUR thousand Semper
med
Semper
flex
Semper
trans
Semper
seal
Semper
form
Corporate
Center
Group
Elimina
tions
Total
Revenue 81,630 138,178 93,643 64,185 59,721 0 0 437,358
Revenue with other segments 0 147 0 0 95 0 –242 0
EBITDA –20,322 32,599 16,693 4,146 10,733 –15,923 0 27,925
EBIT –24,851 26,358 14,286 1,160 8,505 –16,645 0 8,814
Depreciation and amortisation of
intangible assets and property,
plant and equipment
–6,121 –6,241 –2,407 –2,986 –2,227 –722 0 –20,703
Reversal of impairment of
intangible assets and property,
plant and equipment
1,592 0 0 0 0 0 0 1,592
Trade working capital 37,655 61,713 44,634 25,872 23,720 –8,252 0 185,342
Additions to intangible assets
and property, plant and
equipment1
1,375 5,718 925 2,964 2,234 244 0 13,460

1 Excluding right-of-use assets in accordance with IFRS 16

1-6 2023 in EUR thousand Total Adjustments Discontinued +
continued
operations
Discontinued
operations
Continued
operations
Revenue 437,358 18,493 455,851 81,621 374,230
Revenue with other segments 0 0 0 0 0
EBITDA 27,925 260 28,185 –15,548 43,733
EBIT 8,814 5,660 14,474 –13,956 28,430
Depreciation and amortisation of
intangible assets and property,
plant and equipment
–20,703 5,400 –15,303 0 –15,303
Reversal of impairment of
intangible assets and property,
plant and equipment
1,592 0 1,592 1,592 0
Trade working capital 185,342 0 185,342 29,801 155,541
Additions to intangible assets
and property, plant and
equipment1
13,460 0 13,460 905 12,555

1 Excluding right-of-use assets in accordance with IFRS 16

med Semper
flex
Semper
trans
Semper
seal
Semper
form
Corporate
Center
Group
Elimina
tions
Total
173,702 69,825 75,050 53,719 0 0 570,626
0 92 0 67 599 0 –758 0
15,598 46,840 6,609 6,273 8,253 –8,380 0 75,192
2,880 40,887 4,711 2,794 6,109 –8,975 0 48,406
–5,953 –1,898 –3,479 –2,144 –595 0 –26,787
73,294 84,458 27,192 28,960 23,296 –4,427 0 232,773
9,155 3,024 746 3,952 1,870 1,530 0 20,276
Semper
198,330
–12,718

1 Excluding right-of-use assets in accordance with IFRS 16

1-6 2022 in EUR thousand Total Adjustments Discontinued +
continued
operations
Discontinued
operations
Continued
operations
Revenue 570,626 22,535 593,161 198,317 394,844
Revenue with other segments 0 0 0 0 0
EBITDA 75,192 0 75,192 21,264 53,928
EBIT 48,406 0 48,406 9,593 38,812
Depreciation and amortisation of
intangible assets and property,
plant and equipment –26,787 0 –26,787 –11,671 –15,116
Trade working capital 232,773 0 232,773 68,886 163,887
Additions to intangible assets
and property, plant and
equipment1 20,276 0 20,276 8,508 11,768

1 Excluding right-of-use assets in accordance with IFRS 16

The Sempermed segment mainly comprises the production of examination gloves and the produc-tion process required for creating porcelain dip mouldings used to manufacture gloves in Malaysia; the production of surgical gloves in Wimpassing, Austria, by the entity named Semperit Technische Produkte GmbH (STP); their packaging in Sopron, Hungary; as well as global sales and distribution entities. By closing the sale of its medical business expected for 31 August 2023, the Semperit Group will separate itself from the Sempermed segment; for the time being, however, this will not affect the production and packaging of surgical gloves. The Semperit Group will continue to pursue this busi-ness for up to five years until its final sale as a contract manufacturer for HARPS GLOBAL PTE. LTD.; hence this business will remain part of continued operations for the time being. Currently (and in future) the completed and packaged surgical gloves will be sold by STP to Singapore-based Semperit Investments Asia Pte Ltd. (SIA) which is still part of the Group; said entity then resells the products of the Sempermed segment to both intragroup and external customers. In the first half of 2023, the revenue generated between STP and SIA was EUR 18,493 thousand (previous year: EUR 22,535 thousand). As the revenue (of the continued operations) and the cost of materials (of the discontinued operations) from this supplier relationship will continue to exist, the group eliminations of expenses and income were not retained in the presentation to this end. Taking into account the transfer prices applicable to date, this adjustment leads to the corresponding presentation of results in the respective business segments. For the rest, the intragroup transfers between the continued and the discontinued operations were eliminated in full, as previously. The primary expenses underlying the intragroup transfers were allocated to the respective business segments in accordance with the current contractual arrangements with HARPS GLOBAL PTE. LTD.

2.2. Revenue

1-6 2023 in EUR
thousand
Semper
med
Semper
flex
Semper
trans
Semper
seal
Semper
form
Group
Western Europe 9 84,428 31,040 50,871 35,302 201,650
Asia 18,493 11,303 22,254 138 12,661 64,848
North America 0 19,519 17,248 6,292 4,523 47,582
Eastern Europe 0 21,075 8,707 6,875 6,214 42,871
Africa 0 552 9,049 0 272 9,874
Central and
South America
0 812 5,092 9 743 6,657
Australia and
Oceania
0 490 253 0 5 748
Revenue 18,502 138,178 93,643 64,185 59,721 374,230
1-6 2022 in EUR
thousand
Semper
med
Semper
flex
Semper
trans
Semper
seal
Semper
form
Group
Western Europe 13 103,799 23,724 60,917 33,827 222,280
Asia 22,535 12,182 16,011 279 9,932 60,939
North America 0 24,315 7,486 4,948 3,071 39,820
Eastern Europe 0 29,325 12,674 8,900 6,081 56,981
Africa 0 1,154 4,692 0 91 5,937
Central and
South America
0 2,398 3,114 7 701 6,220
Australia and
Oceania
0 527 2,124 0 17 2,668
Revenue 22,548 173,702 69,825 75,050 53,719 394,844

2.3. Cost of materials and purchased services

in EUR thousand 1-6 2023 1-6 2022
Cost of materials 155,486 186,451
Energy expenses 17,837 18,721
Production-related maintenance costs 4,837 4,343
Purchased services 2,668 2,959
Total 180,829 212,475

2.4. Personnel expenses

in EUR thousand 1-6 2023 1-6 2022
Wages 40,620 39,785
Salaries 43,738 41,568
Severance payments 2,369 704
Retirement benefit expenses 614 390
Statutory social security expenses and other compulsory wage-related payments 18,872 17,620
Other social security expenses 1,484 1,480
Total 107,698 101,547

The increase in the cost of severance payments stems mainly from one-off severance payments made to Kristian Brok (COO, departed as at 30 June 2023) in connection with the early termination of his director's contract.

2.5. Other operating expenses

in EUR thousand 1-6 2023 1-6 2022
Outgoing freight 12,532 15,704
Legal, consulting and auditing fees 7,056 6,225
Maintenance and external services 6,355 4,541
Insurance premiums 2,792 2,189
Complaint costs 2,722 8
Travel expenses 2,652 1,720
Energy costs unrelated to production 2,244 2,056
Commission and advertising expenses 1,558 1,162
Software licence expenses 1,365 2,520
Other taxes 1,337 1,030
Waste disposal 1,128 981
Rental and lease expenses 993 1,365
Fees, subscriptions and donations 659 627
Office equipment 469 376
Communications 357 349
Training and education expenses 357 371
Bank expenses and hedging costs 147 149
Valuation allowances (+) / income from the release of valuation allowances (–) –93 –315
Miscellaneous 5,474 5,942
Total 50,103 47,000

The other operating expenses include a total of EUR 2,733 thousand (previous year: EUR 0 thousand) in connection with the acquisition of the Rico Group. Legal, consulting, and auditing expenses account for a total of EUR 2,570 thousand (previous year: EUR 0 thousand) of this amount. The expenses were recognised in the Corporate segment. In future these acquision costs will be allocated to the new Engineered Applications division (see section 8.2).

The increase in complaint costs during the first half of 2023 is due mainly to warranty claims affecting the Sempertrans segment.

2.6. Earnings after taxes from discontinued operations

The income statement for the discontinued operations is presented below:

in EUR thousand 1-6 2023 1-6 2022
Revenue 81,621 198,317
Changes in inventories –958 –16,887
Own work capitalised 146 564
Operating revenue 80,809 181,994
Other operating income 273 217
Cost of material and purchased services –71,973 –118,920
Personnel expenses –14,227 –19,547
Other operating expenses –10,430 –22,481
Earnings before interest, taxes, depreciation and amortisation (EBITDA) –15,548 21,264
Depreciation and amortisation of intangible assets and property, plant and
equipment
0 –11,671
Reversal of impairment of intangible assets and property, plant and equipment 1,592 0
Earnings before interest and taxes (EBIT) –13,956 9,593
Finance income 136 176
Finance expenses –25 –16
Other financial result 266 –290
Financial result 377 –130
Earnings before taxes –13,579 9,463
Income taxes –121 –1,903
Earnings after taxes –13,701 7,560
Transaction costs recognized –260 0
Income taxes on transactions costs recognized 0 0
Result from deconsolidation 0 0
Reclassification of other income to profit/loss for the period 0 0
Subtotal –260 0
Result from discontinued operations –13,961 7,560
thereof earnings attributable to the shareholders of Semperit AG –13,754 7,479
thereof attributable to non-controlling interests –207 81

Earnings after taxes arising from the fair-value measurement less costs to sell correspond to the reversal of impairment losses on intangible assets and property, plant and equipment.

The expenses for material and purchased services comprise the following:

Total 71,973 118,920
Purchased services 135 187
Production-related maintenance costs 1,055 1,644
Energy expenses 17,959 22,183
Cost of materials 52,824 94,905
in EUR thousand 1-6 2023 1-6 2022

The expenses for energy include further increases in provisions by EUR 1,391 thousand (previous year: EUR 0 thousand) related to a natural gas delivery contract containing a take-or-pay clause which runs until the financial year 2024 and is unfavourable to the discontinued operations, given the current market situation.

Personnel expenses comprise the following:

in EUR thousand 1-6 2023 1-6 2022
Outgoing freight 4,656 16,010
Legal, consulting and auditing fees 1,535 617
Maintenance and external services 717 909
Miscellaneous 3,523 4,944
Total 10,430 22,481

A (level 1) fair value was determined in connection with the signing of the Share Purchase Agreement (SPA) with HARPS GLOBAL PTE. LTD. for Sempermed's segment assets as at 30 June 2023 based on the sale price (cash and debt free) and taking into account the price adjustment mechanism set out in the SPA. Directly attributable selling costs which are still expected to be incurred had to be deducted from this fair value.

The resulting reversal of impairment losses on the Sempermed segment as at 30 June 2023 in the amount of EUR 1,515 thousand (previous year: EUR 0 thousand) was allocated to the main noncurrent segment assets and recognised in the functional currencies of the respective subsidiaries at the 30 June 2023 reporting date foreign exchange rate. Translated at the average mid-market foreign exchange rates for the first half of 2023, this yields a gain of EUR 1,592 thousand on the reversal of impairment losses which was attributable in full to the discontinued operations.

Cash flows from the operating, investing and financing activities of the discontinued operations

in EUR thousand 1-6 2023 1-6 2022
Cash flows from operating activities –11,934 47,114
Cash flows from investing activities –1,091 –10,884
Cash flows from financing activities –290 –5,534

3. Non-current assets

3.1. Tangible and intangible assets

Additions to assets in the first half year 2023 (excl. right-of-use assets in accordance with IFRS 16) in continued operations totalled EUR 12,555 thousand (1-6 2022: 11.767 TEUR). EUR 4,038 thousand thereof (1-6 2022: EUR 5.118 thousand) was attributable to Austria, EUR 3,284 thousand (1-6 2022: EUR 1.606 thousand) to the Czech Repubik, EUR 2,1346 thousand (1-6 2022: EUR 1.589 thousand) to Germany, EUR 1,202 thousand (1-6 2022: EUR 251 thousand) to Thailand, and EUR 847 thousand (1-6 2022: EUR 766 thousand) to Poland.

4. Assets, provisions and liabilities held for sale

in EUR thousand 30.06.2023 31.12.2022
Intangible assets 101 99
Property, plant and equipment 72,199 75,328
Other financial assets 47 81
Other assets 33 24
Non-current assets 72,380 75,532
Inventories 31,224 38,597
Trade receivables 16,870 17,520
Other financial assets 394 454
Other assets 1,625 2,528
Current tax receivables 1,663 1,970
Cash and cash equivalents 38,567 51,274
Current assets 90,344 112,343
Assets held for sale 162,725 187,875
Currency translation differences –24,348 –16,989
Provisions 3,416 4,747
Other financial liabilities 541 734
Other liabilities 259 400
Deferred tax assets 9 7
Non-current provisions and liabilities 4,224 5,887
Provisions 8,395 10,904
Trade payables 18,293 19,792
Other financial liabilities 1,925 2,299
Other liabilities 3,976 3,524
Current tax liabilities 3,048 4,503
Current provisions and liabilities 35,637 41,022
Provisions and liabilities held for sale 39,861 46,909

5. Equity

5.1. Dividend

For the financial year 2022, a dividend of EUR 1.50 per share was distributed in the financial year 2023. A dividend payment was made in the previous year in the same amount.

Furthermore, a contingent additional dividend of EUR 3.00 per share (previous year: EUR 0.00 per share) was adopted for the financial year 2022. Any claim to the additional dividend and to distribution thereof are subject to the following conditions precedent: the conditions precedent governing the sale of the medical business shall be fulfilled by 16 September 2023, the transfer of the medical business to HARPS GLOBAL PTE. LTD. shall be completed by 31 October 2023 and the Semperit Group shall receive the purchase price owed in full on the closing date. No dividend liability was recognised because the conditions precedent had not (yet) been fulfilled as at 30 June 2023.

6. Disclosures on financial instruments

6.1. Disclosures on financial assets

The three levels in the fair value hierarchy are defined as follows:

Level 1: measurement based on quoted prices on an active market for a specific financial in
strument
Level 2: measurement based on quoted market prices for similar instruments or on the basis
of valuation models based exclusively on inputs that are observable on the market
Level 3: measurement based on models with significant inputs that are not observable on
the market

The following table shows the carrying amounts of the individual financial assets classified in accordance with the measurement categories pursuant to IFRS 9.

in EUR thousand Measurement category
according IFRS 91
Level Carrying
amount
30.06.2023
Carrying
amount
31.12.2022
Trade receivables AC 99,383 88,861
Other financial assets
Securities FVPL 1 5,453 5,388
Derivative financial instruments FVPL 2 0 233
Miscellaneous other financial assets AC 2,338 2,464
Cash and cash equivalents 88,856 106,631

1 FVPL (fair value through profit and loss); AC (at cost)

The derivative financial instruments (freestanding financial instruments) are foreign exchange forward contracts.

The fair values of the foreign exchange forward contracts are determined using accepted actuarial valuation models. Future payment flows are simulated using the yield curves published at the reporting date. The credit risk of the contractual partners is also taken into account in the valuation.

6.2. Disclosures on financial liabilities

in EUR thousand 30.06.2023 Thereof non
current
Thereof
current
31.12.2022 Thereof non
current
Thereof
current
Corporate Schuldschein loan 53,178 37,963 15,215 52,457 37,956 14,501
Liabilities to banks 9,809 9,809 0 3 0 3
Total 62,987 47,772 15,215 52,460 37,956 14,503

New bank credit facilities with a funding volume of up to EUR 360 million were concluded effective 31 March 2023. A financing agreement regarding a total of EUR 250 million comprises a loan in the amount of up to EUR 150 million and a general credit facility of EUR 100 million. Under this financing agreement Semperit AG Holding undertakes to comply with three ESG key performance indicators (KPIs) which are also part of the Group's "30 by 2030" sustainability strategy. This credit facility is being made available by a consortium consisting of six Austrian and international banks and replaces the old general credit facility of EUR 75 million. The second financing agreement for EUR 110 million was concluded particularly to finance the investments required for expanding Odry. From this financing agreement a EUR 10 million loan was utilized as at 30 June 2023.

The following table shows the carrying amounts of the individual financial liabilities broken down by the measurement categories of IFRS 9.

in EUR thousand Measurement category
according IFRS 91
Level Carrying
amount
30.06.2023
Carrying
amount
31.12.2022
Liabilities from redeemable non-controlling interests AC 13,242 18,907
Corporate Schuldschein loan AC 3 53,178 52,457
Liabilities to banks AC 9,809 3
Trade payables AC 58,630 63,942
Derivative financial instruments FVPL 2 128 1
Derivative financial instruments FVPL 3 2,046 1,922
Lease liabilities AC 20,259 19,952
Miscellaneous other financial
liabilities
AC 8,199 6,603

1) FVPL (fair value through profit and loss); FVOCI (fair value through OCI); AC (at cost)

The derivative financial instruments (freestanding financial instruments) are foreign exchange forward contracts as well as a contingent purchase price liability from the acquisition of M+R Dichtungstechnik GmbH.

The fair values of the foreign exchange forward contracts are determined using accepted actuarial valuation models. Future payment flows are simulated using the yield curves published at the reporting date. The credit risk of the contractual partners is also taken into account in the valuation.

The fair value of the contingent purchase price liability is derived from an average adjusted EBITDA of M+R Dichtungstechnik GmbH for the years 2022 to 2024 and a multiplier. The minimum purchase price is EUR 1,000 thousand less any sales bonuses paid to the managing partner in accordance with the contract. The maximum purchase price is in principle unlimited. The contingent purchase price liability is calculated using probability-weighted purchase price scenarios based on the future development of the business activities of M+R Dichtungstechnik GmbH, and is discounted with a cost of equity rate typically applied on the market.

The fair values of financial liabilities, with the exception of those stated below and the liabilities from redeemable non-controlling interests, equate to the carrying amounts. Actuarial valuation methods are used to determine the fair value of financial instruments for which no active market is available. The parameters relevant to valuation for determining fair values are based in part on forward-looking assumptions.

in EUR thousand Measurement category
according IFRS 91
Level Fair value
30.06.2023
Fair value
31.12.2022
Liabilities
Corporate Schuldschein loan AC 3 51,430 50,052

1 AC (at cost)

The fair value of the corporate Schuldschein loan was determined by discounting the contractual payment streams with current interest rates. The comparable interest rates at the reporting date were derived from capital market yields with matching terms and then adjusted for the current risk and liquidity costs that are observable on the market. These comparable interest rates were derived based on a current assessment of the rating of the Semperit Group.

For information on the valuation of liabilities from redeemable non-controlling interests, please refer to the explanations in the consolidated financial statements as at 31 December 2022.

7. Other

7.1. Related-party transactions with companies and individuals

Outstanding balances and transactions between Semperit AG Holding and its subsidiaries were eliminated in the course of consolidation and are not further discussed here.

B&C KB Holding GmbH is the direct majority shareholder of Semperit AG Holding, and B&C Privatstiftung is the controlling legal entity. B&C Holding Österreich GmbH is the indirect majority shareholder which draws up and publishes consolidated financial statements in which the Semperit Group is consolidated. According to IAS 24, B&C Privatstiftung and all its subsidiaries, joint ventures and associates are related parties of the Semperit Group.

Related parties of the Semperit Group include the members of the Executive and Supervisory Boards of Semperit AG Holding, the managing directors and Supervisory Board members of all companies which directly or indirectly hold a majority stake in Semperit AG Holding, and finally the members of the Executive Board of B&C Privatstiftung and the close family members of these Executive and Supervisory Board members and managing directors. Related-party transactions in the first half year 2023 were as follows:

Transactions in the amount of EUR 336 thousand (1-6 2022: EUR 262 thousand) were effected with unit-it Dienstleistungs GmbH & Co KG in the first half year 2023. These transactions concern the purchase and maintenance of SAP licences and were carried out at arm's length. As at 30 June 2023 there are no liabilities to unit-it Dienstleistungs GmbH & Co KG (31 December 2022: EUR 357 thousand).

Transactions in the amount of EUR 11 thousand were carried out with Grohs Hofer Rechtsanwälte GmbH in the first half year 2023 (1-6 2022: EUR 15 thousand). As at 30 June 2023 there are EUR 7 thou-sand in liabilities (31 December 2022: EUR 0 thousand) to Grohs Hofer Rechtsanwälte GmbH.

Transactions in the amount of EUR 25 thousand were effected with B&C KB Holding GmbH in the first half year 2023 (1-6 2022: EUR 23 thousand). These transactions concern administrative services rendered to the Supervisory Board. As at 30 June 2023 there were liabilities of EUR 15 thousand (31 December 2022: EUR 0 thousand) to B&C KB Holding GmbH.

Transactions in the amount of EUR 161 thousand (1-6 2022: EUR 120 thousand) were effected with Mr Patrick Lackenbucher, managing director of B&C Holding Österreich GmbH, in the first half year 2023. These transactions concern consulting services and were settled at arm's length. As at 30 June 2023 there are open liabilities to Mr Patrick Lackenbucher in the amount of EUR 146 thousand (31 December 2022 : EUR 15 thousand). The consultancy agreement with Mr Lackenbucher was terminated as at 30 June 2023.

Additional related-party transactions involving other companies or individuals are limited in scope and are settled at customary terms.

8. Events after the reporting date

8.1. Acquisition of the Rico Group

On 17 April 2023 Semperit AG Holding came to an agreement with the owners of Upper Austrian RICO Group GmbH regarding the acquisition of 100% of the equity interests in the Rico Group. As a one-stop-shop (OSS) provider of individual synthetics and elastomer projects, the product portfolio of the Rico Group ranges from the manufacture of injection moulding tools, to consulting on component development, all the way to mass production of customer-specific components. The Group focuses on the processing of elastomers, especially liquid and solid silicone. This involves producing the components in single-, double- or multi-shot component injection moulding processes. The technological market leadership of the Rico Group in the processing of liquid and solid silicone, the Group's strong toolmaking expertise in the development of high-precision and highly complex customer solutions, its access to attractive markets as well as its presence in the USA are the main reasons for this business combination.

The acquisition of 100% of the voting shares of the Rico Group gives Semperit AG Holding full control over the following entities:

  • RICO Group GmbH, Thalheim bei Wels, Österreich
  • RICO Elastomere Projecting GmbH, Thalheim bei Wels, Österreich
  • Härtereitechnik Rosenblattl GmbH, Thalheim bei Wels, Österreich
  • Silcoplast AG, Wolfhalden, Schweiz
  • SIMTEC Solicone Parts, LLC, Miramar, Florida, USA

The purchase price (cash and debt free) is EUR 197.5 million and is subject to a customary price ad-justment mechanism at the time the transaction is effected. The investment pay-out for the plant expansion currently under construction in Thalheim (Upper Austria) is also covered by the purchase price. The preliminary purchase price subject to price adjustments is EUR 182.1 million. Under the contractual arrangements, EUR 4.5 million shall be paid three years from the closing date; 90% of the remaining preliminary purchase price, i.e. EUR 159.9 million, were paid on 31 July 2023. This amount was financed via a EUR 150 million bank loan which was taken out on 28 July 2023 (see section 6.2) as well as available cash and cash equivalents. In particular the transaction was contingent on governmental approvals that were granted in July 2023. The closing of the acquisition of the Rico Group took place on 31 July 2023. So far the purchase price allocation pursuant to IFRS 3 is preliminary due to the proximity in time of the closing to the approval of the publication of the half-year report as well as due to the size and complexity of the acquisition.

For the time being the assets and liabilities of the Rico Group are as follows:

in Mio. EUR Fair value at time of
acquisition
(preliminary)
Non-current assets 207.7
Current assets 58.0
Total assets acquired 265.7
Non-current provisions and liabilities 59.1
Current provisions and liabilities 51.9
Total liabilities assumed 111.0
Total identifiable net assets at fair value 154.7
Positive goodwill 27.4
Total amount of consideration (preliminary) 182.1
Revenue 1-6 20231 42.9
Earnings after taxes 1-6 20231 2.7

1 Revenue and earnings after taxes were derived from preliminary interim financial statements prepared in accordance with local accounting rules and for internal reporting purposes

8.2. Ongoing development of the Group's industrial strategy

As part of the ongoing development of the Group's industrial strategy, both the Executive Board and the Supervisory Board of the Semperit Group adopted adjustments of the Group's organisational structure effective 1 July 2023 and divided the existent segments into two divisions:

The Industrial Applications division will focus on industrial applications through highly efficient manufacturing and cost leadership; this includes hydraulic and industrial hoses (formerly the Semperflex segment) and profiles (formerly part of the Semperseal segment). The Engineered Applications division will focus on technical solutions tai-lored to customers' individual needs and comprises escalator handrails, cable car rings as well as other elastomer products built to customer specification (formerly the Semperform segment), including sheetings (formerly part of the Semperseal segment) and conveyor belts (formerly the Sempertrans segment); the Rico Group (see section 8.1) will also be part of this division. Each of these two divisions targets different customer groups and their specific technical and organisational requirements.

The segment reporting for the first half year 2023 would be structured as follows on account of the organisational adjustments:

1-6 2023 in EUR thousand Industrial
Applications
Engineered
Applications
Sempermed Corporate Group
Elimina
tions
Total
Revenue 192,333 163,395 81,630 0 0 437,358
Revenue with other segments 156 92 0 0 –248 0
EBITDA 35,262 28,908 –20,322 –15,923 0 27,925
EBIT 26,398 23,911 –24,851 –16,645 0 8,814
Depreciation and amortisation of intangible
assets and property, plant and equipment
–8,864 –4,997 –6,121 –722 0 –20,703
Reversal of impairment losses of intangible
assets and property, plant and equipment
0 0 1,592 0 0 1,592
Trade working capital 84,058 71,881 37,655 –8,252 0 185,342
Additions to intangible assets and property,
plant and equipment1
8,181 3,660 1,375 244 0 13,460

1 Excluding right-of-use assets in accordance with IFRS 16

1-6 2022 in EUR thousand Industrial
Applications
Engineered
Applications
Sempermed Corporate Group
Elimina
tions
Total
Revenue 237,514 134,782 198,330 0 0 570,626
Revenue with other segments 122 599 0 0 –721 0
EBITDA 51,455 16,520 15,598 –8,380 0 75,192
EBIT 42,337 12,163 2,880 –8,975 0 48,406
Depreciation and amortisation of intangible
assets and property, plant and equipment
–9,118 –4,357 –12,718 –595 0 –26,787
Trade working capital 109,304 54,601 73,294 –4,427 0 232,773
Additions to intangible assets and property,
plant and equipment1
6,708 2,884 9,155 1,530 0 20,276

1 Excluding right-of-use assets in accordance with IFRS 16

The new divisional structure may be allocated as follows to the previously existing segments:

1-6 2023 in EUR thousand Industrial
Applications
Group
Elimina
tions
Semperflex Profiles2
Revenue 192,333 0 138,178 54,155
Revenue with other segments 156 0 147 9
EBITDA 35,262 0 32,599 2,664
EBIT 26,398 0 26,358 40
Depreciation and amortisation of intangible assets and property,
plant and equipment
–8,864 0 –6,241 –2,623
Trade working capital 84,058 0 61,713 22,345
Additions to intangible assets and property, plant and
equipment1
8,181 0 5,718 2,463

1 Excluding right-of-use assets in accordance with IFRS 16

2 Previously part of Semperseal

tions Semperflex Profiles2
0 173,702 63,813
0 92 31
0 46,840 4,615
0 40,887 1,450
0 –5,953 –3,165
0 84,458 24,847
0 3,024 3,685
Elimina

1 Excluding right-of-use assets in accordance with IFRS 16

2 Previously part of Semperseal

1-6 2023 in EUR thousand Engineered
Applications
Group
Elimina
tions
Sempertrans Semperform Sheeting2
Revenue 163,395 0 93,643 59,721 10,031
Revenue with other segments 92 –4 0 95 0
EBITDA 28,908 0 16,693 10,733 1,483
EBIT 23,911 0 14,286 8,505 1,120
Depreciation and amortisation of intangible assets and property,
plant and equipment
–4,997 0 –2,407 –2,227 –363
Trade working capital 71,881 0 44,634 23,720 3,528
Additions to intangible assets and property, plant and
equipment1
3,660 0 925 2,234 501

1 Excluding right-of-use assets in accordance with IFRS 16

2 Previously part of Semperseal

1-6 2022 in EUR thousand Engineered
Applications
Group
Elimina
tions
Sempertrans Semperform Sheeting2
Revenue 134,782 0 69,825 53,719 11,238
Revenue with other segments 599 –67 0 599 67
EBITDA 16,520 0 6,609 8,253 1,658
EBIT 12,163 0 4,711 6,109 1,344
Depreciation and amortisation of intangible assets and property,
plant and equipment
–4,357 0 –1,898 –2,144 –314
Trade working capital 54,601 0 27,192 23,296 4,113
Additions to intangible assets and property, plant and
equipment1
2,884 0 746 1,870 268

1 Excluding right-of-use assets in accordance with IFRS 16

2 Previously part of Semperseal

Vienna, 9 August 2023

The Executive Board

Dr. Karl Haider CEO

Dr. Helmut Sorger CFO

Mag. Gerfried Eder CIO

Statement of all legal representatives

Pursuant to Section 125 (1) (3) of the Austrian Stock Exchange Act

We confirm to the best of our knowledge that the interim consolidated financial statements give a true and fair view of the assets, liabilities, financial position and profit or loss of the group as required by the applicable accounting standards and that the group management report gives a true and fair view of important events that have occurred during the first six months of the financial year and their impact on the interim consolidated financial statements, of the principal risks and uncertainties for the remaining six months of the financial year and of the major related party transactions to be disclosed

Vienna, 9 August 2023

The Executive Board

Dr. Karl Haider CEO

Dr. Helmut Sorger CFO

Mag. Gerfried Eder CIO

Contact

Semperit AG Holding

Am Belvedere 10 1100 Vienna, Austria Tel.: +43 1 79 777 0 Fax: +43 1 79 777 600 www.semperitgroup.com/en

Investor Relations

Judit Helenyi Director Investor Relations Tel.: +43 1 79 777 310 www.semperitgroup.com/en/ir

Addresses of the Semperit Group

www.semperitgroup.com/en/contact

Contacts of the Semperit Group

Ownership and publisher: Semperit Aktiengesellschaft Holding, Am Belvedere 10, 1100 Vienna, Austria, Produced in-house with firesys GmbH, www.firesys.de

Disclaimer

The terms "Semperit" or "Semperit Group" in this report refer to the group; "Semperit AG Holding" or "Semperit Aktiengesellschaft Holding" is used to refer to the parent company (individual company).

We have prepared this report and verified the information it contains with the greatest possible care. Nevertheless, rounding, typesetting and printing errors cannot be ruled out. Rounding of differences in the summation rounded amounts and percentages may arise from the automatic processing of data.

The forecasts, plans and forward-looking statements contained in this report are based on the knowledge and information available and the assessments made at the time that this report was prepared (editorial deadline: 09 August 2023). As is true of all forward-looking statements, these statements are subject to risk and uncertainties. As a result, actual events may deviate significantly from these expectations. No liability whatsoever is assumed for the accuracy of projections or for the achievement of planned targets or for any other forward-looking statements. Words such as "expect," "want", "believe," "anticipate," "includes," "plan," "assumes," "estimate," "projects," "intends," "should," "will," "shall," or variations of such words are generally part of forward-looking statements.

Furthermore, there is no guarantee that the contents are complete.

Statements referring to people are valid for both men and women.

This report has been written in German and English. In case of doubt, the German version shall take precedence.

Financial Calendar 2023

10.08.2023 Half-year financial report 2023
08.11.2023 Report on Q1-3 2023

Talk to a Data Expert

Have a question? We'll get back to you promptly.